![](/img/cover-not-exists.png)
Patients at risk for post-transplant lymphoproliferative disease can be identified in the first months after lung transplantation by quantitative-competitive-EBV-PCR
E.A. Verschuuren, S. Stevens, B.B. Hanekamp, C. De Boer, M.C. Harmsen, J.M. Middeldorp, G. Koeter, T.H. The, W. Van Der BijVolume:
20
Year:
2001
Language:
english
DOI:
10.1016/s1053-2498(00)00423-x
File:
PDF, 80 KB
english, 2001